April 30, 2016
Recommended Topic Related To:

Amerge

"Jan. 15, 2013 -- Women who have migraine with aura may have a higher risk of heart attacks, and they may face a higher risk of dangerous blood clots if they use certain hormonal contraceptives.

Those are the findings from two newly pu"...

A A A

Amerge




Indications
Dosage
How Supplied

INDICATIONS

AMERGE® is indicated for the acute treatment of migraine with or without aura in adults.

Limitations Of Use

  • Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with AMERGE, reconsider the diagnosis of migraine before AMERGE is administered to treat any subsequent attacks.
  • AMERGE is not indicated for the prevention of migraine attacks.
  • Safety and effectiveness of AMERGE have not been established for cluster headache.

DOSAGE AND ADMINISTRATION

Dosing Information

The recommended dose of AMERGE is 1 mg or 2.5 mg.

If the migraine returns or if the patient has only partial response, the dose may be repeated once after 4 hours, for a maximum dose of 5 mg in a 24-hour period.

The safety of treating an average of more than 4 migraine attacks in a 30-day period has not been established.

Dosage Adjustment In Patients With Renal Impairment

AMERGE is contraindicated in patients with severe renal impairment (creatinine clearance: < 15 mL/min) because of decreased clearance of the drug [see CONTRAINDICATIONS, Use in Specific Populations, CLINICAL PHARMACOLOGY].

In patients with mild to moderate renal impairment, the maximum daily dose should not exceed 2.5 mg over a 24-hour period and a 1-mg starting dose is recommended [see Use in Specific Populations, CLINICAL PHARMACOLOGY].

Dosage Adjustment In Patients With Hepatic Impairment

AMERGE is contraindicated in patients with severe hepatic impairment (Child-Pugh Grade C) because of decreased clearance [see CONTRAINDICATIONS, Use in Specific Populations, CLINICAL PHARMACOLOGY].

In patients with mild or moderate hepatic impairment (Child-Pugh Grade A or B), the maximum daily dose should not exceed 2.5 mg over a 24-hour period and a 1-mg starting dose is recommended [see Use in Specific Populations, CLINICAL PHARMACOLOGY].

HOW SUPPLIED

Dosage Forms And Strengths

1-mg white tablets, D-shaped, film-coated, and debossed with “GX CE3”

2.5-mg green tablets, D-shaped, film-coated, and debossed with “GX CE5”

Storage And Handling

AMERGE tablets containing 1 mg and 2.5 mg of naratriptan (base) as the hydrochloride salt.

AMERGE tablets, 1 mg, are white, D-shaped, film-coated tablets debossed with “GX CE3” on one side in blister packs of 9 tablets (NDC 0173-0561-00).

AMERGE tablets, 2.5 mg, are green, D-shaped, film-coated tablets debossed with “GX CE5” on one side in blister packs of 9 tablets (NDC 0173-0562-00).

Store at controlled room temperature, 20° to 25°C (68° to 77°F) [see USP].

GlaxoSmithKline, Research Triangle Park, NC 27709. Revised: August 2015

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 3/21/2016

Indications
Dosage
How Supplied

Amerge - User Reviews

Amerge User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Amerge sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Living Better

Find the secrets to longer life.